Orchestra BioMed™ Secures $20 Million Financing Facility from Silicon Valley Bank
Biospace,
NEW YORK, Dec. 10, 2019 (GLOBE NEWSWIRE) -- (“Orchestra BioMed” or the “Company”), a biomedical innovation company providing…
Orchestra BioMed™ Secures $20 Million Financing Facility from Silicon Valley Bank
USA Life Sciences Database,
Orchestra BioMed™ Secures $20 Million Financing Facility from Silicon Valley Bank NEW YORK, Dec.
Orchestra BioMed™ Secures $20 Million Financing Facility from Silicon Valley Bank
GlobeNewswire,
NEW YORK, Dec. 10, 2019 (GLOBE NEWSWIRE) --, Inc. (“Orchestra BioMed” or the “Company”), a biomedical innovation company…
Orchestra BioMed™ to Present at the Innovation in Cardiovascular Interventions Meeting and the CSI Focus D-HF Congress
USA Life Sciences Database,
NEW HOPE, Pa., Dec. 05, 2019 (GLOBE NEWSWIRE) -- Orchestra BioMed, Inc. (“Orchestra BioMed” or the “Company”), a biomedical…
Orchestra BioMed™ to Present at the Innovation in Cardiovascular Interventions Meeting and the CSI Focus D-HF Congress
BioTech Gate,
NEW HOPE, Pa., Dec. 05, 2019 (GLOBE NEWSWIRE) -- Orchestra BioMed, Inc. (“Orchestra BioMed” or the “Company”), a biomedical…
Orchestra BioMed™ to Present at the Innovation in Cardiovascular Interventions Meeting and the CSI Focus D-HF Congress
Biospace,
NEW HOPE, Pa., Dec. 05, 2019 (GLOBE NEWSWIRE) -- Orchestra BioMed, Inc. (“Orchestra BioMed” or the “Company”), a biomedical…
Orchestra BioMed™ to Present at the Innovation in Cardiovascular Interventions Meeting and the CSI Focus D-HF Congress
Jotup,
Orchestra BioMeds CE Mark-approved Moderato implantable pulse generator system delivers BackBeat CNT while also providing…
Orchestra BioMed™ to Present at the Innovation in Cardiovascular Interventions Meeting and the CSI Focus D-HF Congress
TMCnet.com,
NEW HOPE, Pa., Dec. 05, 2019 (GLOBE NEWSWIRE) -- Orchestra BioMed, Inc. (“Orchestra BioMed” or the “Company”), a biomedical…
Orchestra BioMed™ to Present at the Innovation in Cardiovascular Interventions Meeting and the CSI Focus D-HF Congress
Morning Star,
NEW HOPE, Pa., Dec. 05, 2019 (GLOBE NEWSWIRE) -- Orchestra BioMed, Inc. (“Orchestra BioMed” or the “Company”), a biomedical…
Orchestra BioMed™ to Present at the Innovation in Cardiovascular Interventions Meeting and the CSI Focus D-HF Congress
GlobeNewswire,
NEW HOPE, Pa., Dec. 05, 2019 (GLOBE NEWSWIRE) --, Inc. (“Orchestra BioMed” or the “Company”), a biomedical innovation company…
Orchestra BioMed™ to Present at the Innovation in Cardiovascular Interventions Meeting and the CSI Focus D-HF Congress
Bioportfolio,
NEW HOPE, Pa., Dec. 05, 2019 (GLOBE NEWSWIRE) -- Orchestra BioMed, Inc. (“Orchestra BioMed” or the “Company”), a biomedical…
Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease
USA Life Sciences Database,
First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-k…
Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease
BioTech Gate,
First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-k…
Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease
TMCnet.com,
First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-k…
Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease
Benzinga,
First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-k…
Sirolimus angioplasty balloon shows promise for in-stent restenosis treatment
Healio.com,
A sirolimus-eluting angioplasty balloon appears to be safe and effective in the treatment of patients with in-stent restenosis…